Your session is about to expire
← Back to Search
AI-Powered Device for Chronic Insomnia in Cancer Survivors
Study Summary
This trial is testing an AI-powered device to help young adult cancer survivors with chronic sleep disorders using cognitive behavioral therapy. #CBTI #VAVA #SleepDisorders
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are expected to live for less than a year.You are between 18 and 29 years old.You have a disorder that you were born with or that developed as you grew up.You have had any type of cancer at any stage in the past.You have been consistently getting less sleep than what is recommended for your age by the National Sleep Foundation for at least 3 months.
- Group 1: Intervention arm
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research initiative open to individuals aged 45 and older?
"The requirements for enrolment in this clinical trial specifies the minimum age of consent and a maximum age limit of 29 years old."
Is there an eligibility criterion that would permit me to join this medical experiment?
"Patients suffering from cancer and aged 18-29 may be accepted into this trial, with a maximum of 15 eligible participants."
Are enrollment opportunities still available for this medical experiment?
"Clinicaltrials.gov records that this medical trial is not presently taking on new participants; the study was initially posted June 1st 2023, and edited most recently May 22nd 2023. Nonetheless, there are 737 other studies actively recruiting patients at present time."
Share this study with friends
Copy Link
Messenger